Comparing combined trabeculotomy-trabeculectomy with gonioscopy-assisted transluminal trabeculotomy as primary surgery for primary congenital glaucoma

比较小梁切开-小梁切除联合手术与房角镜辅助经管腔小梁切开术作为原发性先天性青光眼的一线手术

阅读:2

Abstract

PURPOSE: The purpose of this study was to compare surgical outcomes and safety profiles of gonioscopy-assisted transluminal trabeculotomy (GATT) versus combined trabeculectomy and trabeculotomy (CTT) in primary congenital glaucoma (PCG) at 12 months. DESIGN: Retrospective comparative analysis. METHODS: Children with mild-to-moderate PCG who underwent either GATT or CTT between December 2021 and June 2023 were included. Patients' data recorded at baseline and at postoperative periods of 1st, 3rd, 6th, and 12th months were analyzed. Intraocular pressure (IOP) reduction, incidence of complications, and the need for repeat examinations under anesthesia (EUA) were analyzed. Surgical success was defined as absolute when IOP ≤18 (criterion A) and ≤15 mmHg (criterion B) was achieved without medications and qualified, when achieved with medications. Failure was defined as IOP >18 mmHg on maximal medical therapy, IOP <6 mmHg, or the need for additional IOP-lowering surgery. Multivariate regression analysis was used to assess baseline predictors for binary outcomes (surgical success and any complication). RESULTS: Ninety-eight eyes from 68 children diagnosed with PCG were analyzed, having undergone either CTT (58 eyes) or GATT (40 eyes) with 12-month follow-up, which showed similar success rates (P = 0.6, Log Rank test). Multivariate analysis did not identify any significant baseline predictors of surgical success. Postoperative complications (34% vs 20%; adjusted P = 0.02) and need for repeat EUAs (0 vs 1.27/eye; P = 0.05) were significantly higher in the CTT group. CONCLUSIONS: In mild-moderate PCG eyes, GATT demonstrated similar surgical success with a better safety profile than CTT and can be preferred as the first-line surgical modality.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。